Impact of HER2-low status on axillary response and surgical management after neoadjuvant chemotherapy in early breast cancer

被引：0
|
作者：
da Silva, Leonardo Roberto
Sartori, Guilherme
Ramalho, Susana
Reinert, Tomas
Da Rosa, Mahira Lopes
Tavares, Grazielle Morais
Mantovani, Higor
Vasconcelos, Vivian
Cabello, Ana Elisa Ribeiro Da Silva
Coelho, Guilherme
Mandelli, Jovana
Zaffaroni, Facundo
Barrios, Carlos
Graudenz, Marcia Silveira
Cabello, Cesar
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-17-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-17-12
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer
    Kang, S.
    Lee, S. H.
    Lee, H. J.
    Jeong, H.
    Jeong, J-H.
    Kim, J. E.
    Ahn, J-H.
    Jung, K. H.
    Kim, H. H.
    Lee, S.
    Lee, J.
    Kim, S-B.
    ANNALS OF ONCOLOGY, 2023, 34 : S305 - S305
  • [32] Real-World Data on Pathological Response and Survival Outcomes After Neoadjuvant Chemotherapy in HER2-Low Breast Cancer Patients
    Guan, Dandan
    Shi, Qingyang
    Zheng, Yajuan
    Zheng, Chaopeng
    Meng, Xuli
    CLINICAL BREAST CANCER, 2024, 24 (05) : 463 - 472.e2
  • [33] Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer
    Kang, Sora
    Lee, So Heun
    Lee, Hee Jin
    Jeong, Hyehyun
    Jeong, Jae Ho
    Kim, Jeong Eun
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Gong, Gyungyub
    Kim, Hak Hee
    Lee, Saebyeol
    Lee, Jongwon
    Kim, Sung-Bae
    EUROPEAN JOURNAL OF CANCER, 2023, 191
  • [34] The impact of the HER2-low status on conditional survival in patients with breast cancer
    Ma, Teng
    Liu, Changgen
    Ma, Tianyi
    Sun, Xinyi
    Cui, Jian
    Wang, Lulu
    Mao, Yan
    Wang, Haibo
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [35] Impact of Imaging After Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer
    Breese, Rebecca
    Pu, Tracey
    Arif, Fatima
    Bennett, Stephanie
    Reed, Jennifer
    Friend, Kara
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S429 - S430
  • [36] Favorable effect of HER2-low expression on prognosis for breast cancers after neoadjuvant chemotherapy
    Zhao, Yingying
    Yin, Wenjin
    Chen, Xinru
    Lu, Jingsong
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Analyzing Neoadjuvant Chemotherapy Effects in HER2-Low Breast Cancer: Real World Data
    Antonini, Marcelo
    Mattar, Andre
    Richter, Fernanda G.
    Ramos, Marcellus N.
    Teixeira, Marina D.
    Pantarotto, Nathalia N.
    Matta, Nadia F.
    Amorim, Andressa G.
    Pinheiro, Denise J.
    Lopes, Reginaldo C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [38] HER2-low status in inflammatory breast cancer (IBC) is associated with hormone receptors positivity but not with pathological response to neoadjuvant chemotherapy or overall survival
    de Nonneville, Alexandre
    Finetti, Pascal
    Boudin, Laurys
    Usclade, Lucas
    Viens, Patrice
    Viret, Frederic
    Mamessier, Emilie
    Goncalves, Anthony
    Bertucci, Francois
    CANCER RESEARCH, 2024, 84 (09)
  • [39] Axillary management after neoadjuvant chemotherapy in initially node positive early breast cancer
    Morales Murillo, Serafin
    Gasol Cudos, Ariadna
    Pallise Subirats, Ona
    Mele Olive, Jordi
    Canosa Morales, Carles
    Vilardell Villellas, Felip
    Sanchez Guzman, Douglas Rene
    Veas Rodriguez, Joel
    Rodriguez Galindo, Alvaro
    CANCER RESEARCH, 2021, 81 (04)
  • [40] Breast and axillary downstaging after neoadjuvant chemotherapy in breast cancer: surgical technique
    D'Alonzo, M.
    Minella, C.
    Villasco, A.
    Accomasso, F.
    Biglia, N.
    BREAST, 2021, 56 : S51 - S51
12345